NAFDAC To Continue Hydroxychloroquine Clinical Trial For COVID-19 Treatment Despite WHO’s…
National Agency for Food and Drug Administration (NAFDAC) has announced the continuation of Hydroxychloroquine clinical trial as treatment for COVID-19 patients in the country.
This comes a day after World Health Organization (WHO)…